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been well documented and reports of transcriptional re-
pression during tumour progression are increasing. This re-
view examines the role of posttranslational truncation of E-
cadherin in cancer cells focusing on implications for tumour 
progression. The various proteins involved in the directed 
cleavage of E-cadherin and consequences of these trunca-
tions are discussed.  Copyright © 2007 S. Karger AG, Basel 
 E-Cadherin-Mediated Cell Adhesion 
 Classical adherens junctions, tight junctions, gap junc-
tions and desmosomal junctions are responsible for con-
trolling secure cell-to-cell contact in epithelia, maintain-
ing epithelial cell polarity and tissue integrity. E-cadherin 
(also known as uvomorulin, cell-CAM 120/80 or L-
CAM) is a member of the cadherin family of transmem-
brane adhesion proteins that form adherens junctions 
[Angst et al., 2000]. E-cadherin is a 124-kDa, epithelial-
specific glycoprotein involved in many cellular processes 
including adhesion, recognition, signalling, communica-
tion, morphogenesis and oncogenesis [Ivanov et al., 2001]. 
E-cadherin homodimers are located at the cell membrane 
where they interact with E-cadherin dimers on adjacent 
cells in a calcium-dependent manner [Ivanov et al., 2001]. 
Interaction of E-cadherin with the actin cytoskeleton is 
mediated by the cytoplasmic proteins   -,   - and   -catenin 
resulting in stabilized adherens complexes and polarized 
epithelial cells [Hirano et al., 1987; Ozawa et al., 1989; 
Noritake et al., 2004]. Alterations in cell-cell contacts, in-
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 Abstract 
 Stable intraepithelial adhesion complexes are essential for 
the maintenance of epithelial integrity. Alterations in these 
complexes are key events in the development and progres-
sion of many diseases. One of the major proteins involved in 
maintaining epithelial cell-cell adhesion is the cell-adhesion 
junction protein E-cadherin, a member of the cadherin fam-
ily of transmembrane adhesion proteins. E-cadherin is in-
volved in many cellular processes including morphogenesis, 
adhesion, recognition, communication and oncogenesis. In-
activation of its adhesive properties is often a key step in 
tumour progression and metastasis, leading to its recent de-
scription as a tumour suppressor gene. Mutations of the E-
cadherin gene CDH1 in gastric and mammary cancers have 
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Abbreviations used in this paper
E-cad100 100-kDa E-cadherin fragment
EMT epithelial-mesenchymal transition
HAV histadine alanine valine
HGF/SF hepatocyte growth factor/scatter factor
MMP matrix metalloproteinase
sE-cad soluble E-cadherin
SL-1 stromelysin-1
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cluding those that involve E-cadherin, occur to facilitate 
normal physiological processes such as morphogenesis, 
epithelial-mesenchymal transition (EMT) during organ-
ogenesis, cell division and apoptosis [Reinsch and Karsen-
ti, 1994; Ivanov et al., 2001; Steinhusen et al., 2001; Zhu 
et al., 2001; Li et al., 2003; Shen and Kramer, 2004]. Dis-
ruption of cell-cell contacts and cell migration are key 
events in EMT and are increasingly linked with tumour 
progression, invasion and dissemination. While these 
may be critical to early stages of tumour progression, 
good evidence is emerging to indicate that re-expression 
of E-cadherin/re-epithelialization at the site of metastasis 
favours growth of the secondary tumour [see Chaffer et 
al., 2006, this volume], suggesting a dynamic regulation 
throughout the metastasis process. Improved under-
standing of underlying mechanisms would contribute to 
identification of prognostic markers and novel therapeu-
tic targets. 
 The regulation of cell adhesion complex proteins, and 
specifically E-cadherin, during disease processes has be-
come the focus of intensive research. Investigations into 
reduced E-cadherin function in cancer have included he-
reditary mutational analysis, promoter hypermethyl-
ation analysis, transcriptional repression analysis and 
posttranslational modification studies. Posttranslational 
truncation of E-cadherin and subsequent disruption of 
cell adhesion appear to facilitate tumour dissemination. 
Furthermore, the resulting increase in cytoplasmic   -
catenin levels can enhance proliferation via the wnt sig-
nalling pathway [Korinek et al., 1997]. In this paper, we 
review the evidence that posttranslational truncation of 
E-cadherin is associated with tumour progression. 
 Posttranslational Truncation of E-Cadherin 
 Posttranslational modification of E-cadherin occurs 
during normal maturation of the protein. E-cadherin is 
synthesized as a 135-kDa inactive precursor protein [Pey-
rieras et al., 1983]. Maturation in the Golgi network in-
volves proteolytic cleavage of pro-E-cadherin near the N-
terminus at a specific recognition sequence [Arg/Lys-
(X) n -Lys/Arg-Arg] (n = 0, 2, 4 or 6) by a subtilisin-like 
proprotein convertase ( fig. 1 a). Once processed the func-
tional mature E-cadherin protein is translocated to the 
cell membrane ( fig. 1 b). While pro-E-cadherin can inte-
grate into the cell membrane, it lacks adhesive ability, in-
dicating that proteolytic processing is essential for the 
adhesive function of E-cadherin [Ozawa and Kemler, 
1990].
 The first alternative form of E-cadherin described was 
a soluble 80-kDa protein, gp80, which was subsequently 
found to be soluble E-cadherin (sE-cad) ( fig. 1 c). This 
protein is constitutively released into culture medium by 
MCF-7 human mammary carcinoma cells. sE-cad-con-
taining conditioned medium inhibits aggregation of cul-
tured epithelial cells and prevents cell compaction at the 
eight-cell stage of mouse embryogenesis [Damsky et al., 
1983; Wheelock et al., 1987]. This truncated form of E-
cadherin may function as a pseudo-ligand that blocks 
normal E-cadherin interactions, resulting in reduced ad-
hesion. Elevated levels of sE-cad have also been detected 
in vivo in serum and urine of cancer patients, suggesting 
a link between E-cadherin truncation and tumourigen-
esis [Katayama et al., 1994; Banks et al., 1995; Griffiths et 
al., 1996; Gofuku et al., 1998; Protheroe et al., 1999; 
Rashid et al., 2001].
 Studies involving the matrix metalloprotease (MMP) 
stromelysin-1 (SL-1) indicate that sE-cad occurs as a re-
sult of protease-mediated truncation of E-cadherin 
[Lochter et al., 1997]. Lochter et al. detected soluble 95- 
and 80-kDa fragments that react with the ECCD-2 anti-
E-cadherin antibody following overexpression of SL-1 in 
SCp2 mammary epithelial cells. Appearance of these 
fragments was inhibited by the GM6001 general MMP 
inhibitor. A 40-kDa ECCD-2-reactive fragment is also 
detected regardless of SL-1 presence. SL-1 expression in-
duces cell scattering, an invasive phenotype and expres-
sion of a mesenchymal-like cytoskeleton with decreased 
cytokeratin and increased vimentin expression. While 
increased keratinocyte growth factor mRNA expression 
also occurs, recombinant keratinocyte growth factor 
alone is not enough to induce the phenotypic changes in-
duced by SL-1. The MMP family of proteases regulates 
ductal morphogenesis, apoptosis and neoplastic progres-
sion in mammary epithelial cells [Lochter et al., 1997]. 
MMPs were traditionally thought to contribute to tu-
mourigenesis solely via degradation of the extracellular 
matrix, thereby facilitating invasion during tumour pro-
gression. It now appears, however, that SL-1 activity has 
multiple consequences for epithelial cells and may play a 
direct role in tumour cell invasion and cancer progres-
sion.
 The role of MMPs in sE-cad production is further sub-
stantiated by Noe et al. [2000] who demonstrate increased 
release of sE-cad by MDCK kidney epithelial cells follow-
ing treatment with recombinant SL-1, or matrilysin, an-
other MMP. The presence of the MMP inhibitor TIMP-2 
reduces levels of sE-cad in MCF-7 breast carcinoma cells. 
Purified and immobilized E-cadherin protein from both 
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MDCK and MCF-7 cells are directly cleaved by SL-1 and 
matrilysin to yield 80- and 40-kDa fragments. Condi-
tioned medium from SL-1- and matrilysin-treated MDCK 
cells inhibits cell aggregation and induces a more invasive 
phenotype. Thus the MMPs SL-1 and matrilysin can di-
rectly cleave E-cadherin to produce a soluble fragment 
that can increase invasion and inhibit cell aggregation in 
an autocrine manner.
 Another protease implicated in the creation of trun-
cated E-cadherin during tumour progression is calpain, 
a ubiquitously expressed protease involved in cell cycle 
regulation, signal transduction, cell migration and apop-
tosis. Calpain induces the accumulation of a 100-kDa E-
cadherin fragment (E-cad 100 ) in prostate LNCaP and 
breast MCF-7 epithelial cells ( fig. 1 d) [Rios-Doria et al., 
2003]. Both   - and m-calpain directly cleave E-cadherin 
to produce E-cad 100 . The calpain cleavage site is located 
upstream of the   - and   -catenin binding domains of the 
cytoplasmic tail of E-cadherin, and amino acid residues 
782–787 are essential for calpain-mediated cleavage. 
m-Calpain expression is increased in localized and meta-
static prostate cancer compared to benign prostate tu-
mours and correlates with the appearance of E-cad 100  in 
the tumour aspect of prostate tissue when compared to 
normal tissue. E-cad 100  was also observed in all matched 
prostate metastases. Therefore, calpain expression is as-
sociated with prostate tumourigenesis, and calpain-me-
diated cleavage of E-cadherin is correlated with inactiva-
tion, specifically in prostate cancer and metastases 
[Rashid et al., 2001; Rios-Doria et al., 2003]. Calpain-me-
diated release of the catenin binding domain of E-cad-
herin may support the malignant transformation of these 
cells and contribute to destabilizing the adhesive func-
tion of E-cadherin.
 Although proteolytic cleavage of E-cadherin has been 
associated with tumour progression, the mechanisms by 
which alternative forms of E-cadherin may facilitate car-
cinogenesis remain unclear. Hepatocyte growth factor/
Metalloproteinase
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 Fig. 1. Schematic diagram of E-cadherin and its posttranslational truncation products.  a Pro-E-cadherin is 
cleaved near the N-terminus by a subtilisin-like proprotein convertase removing a precursor 15-kDa peptide 
(PRE).  b Mature E-cadherin integrates into the cell membrane (MEM) and homodimers interact with dimers 
on adjacent epithelial cells.  c Metalloproteinases cleave E-cadherin near the plasma membrane on the extracel-
lular side.  d Calpain cleaves E-cadherin upstream of the   - and   -catenin binding domains of the cytoplasmic 
tail. 
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